标题
Addressing the Challenges of Tuberculosis: A Brief Historical Account
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-09-26
DOI
10.3389/fphar.2017.00689
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application
- (2017) Christopher A. Kerantzas et al. mBio
- Screening for Latent Tuberculosis Infection in Adults
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
- (2015) Rohit Vashisht et al. Journal of Translational Medicine
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
- (2015) Jan Rybniker et al. Nature Communications
- Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis
- (2015) Surendra K Sharma et al. PLoS One
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand
- (2014) Angkanang Sowajassatakul et al. BMC MICROBIOLOGY
- An update on the use of rifapentine for tuberculosis therapy
- (2014) John Gar Yan Chan et al. Expert Opinion on Drug Delivery
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- A review of tuberculosis: Focus on bedaquiline
- (2013) B. Chan et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis
- (2013) Woojin Lew et al. ANNALS OF INTERNAL MEDICINE
- Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China
- (2013) Qing Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- TheMycobacterium tuberculosisSecreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11
- (2013) Cedric P. Owens et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
- (2013) Cristina Vilaplana et al. JOURNAL OF INFECTIOUS DISEASES
- Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment
- (2013) Juraj Ivanyi et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis biomarkers discovery: developments, needs, and challenges
- (2013) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- When to Start ART in Africa — An Urgent Research Priority
- (2013) Kevin M. De Cock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
- (2013) Juan D Guzman et al. BMJ Open
- Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains
- (2012) L. E. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
- (2012) David M. Tobin et al. CELL
- Towards a new tuberculosis drug: pyridomycin - nature's isoniazid
- (2012) Ruben C. Hartkoorn et al. EMBO Molecular Medicine
- Strategies for potentiation of ethionamide and folate antagonists againstMycobacterium tuberculosis
- (2012) Kerstin A Wolff et al. Expert Review of Anti-Infective Therapy
- Adjunct Immunotherapies for Tuberculosis
- (2012) M. Uhlin et al. JOURNAL OF INFECTIOUS DISEASES
- Investing in Improved Performance of National Tuberculosis Programs Reduces the Tuberculosis Burden: Analysis of 22 High-Burden Countries, 2002–2009
- (2012) Yoko Akachi et al. JOURNAL OF INFECTIOUS DISEASES
- Advancing the development of tuberculosis therapy
- (2012) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
- (2012) Mamoudou Maiga et al. PLoS One
- Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas
- (2012) Ciaran Skerry et al. PLoS One
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
- (2011) Ruth J. Napier et al. Cell Host & Microbe
- Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience
- (2011) A. D. Pranger et al. EUROPEAN RESPIRATORY JOURNAL
- Initiating antiretrovirals during tuberculosis treatment: a drug safety review
- (2011) Tanuja N Gengiah et al. Expert Opinion On Drug Safety
- Tuberculosis
- (2011) Stephen D Lawn et al. LANCET
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
- (2011) François-Xavier Blanc et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
- (2011) Diane V. Havlir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tuberculosis vaccines: beyond bacille Calmette-Guerin
- (2011) H. McShane PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Global tuberculosis drug development pipeline: the need and the reality
- (2010) Zhenkun Ma et al. LANCET
- Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
- (2010) Keertan Dheda et al. LANCET
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- (2010) Neel R Gandhi et al. LANCET
- Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study
- (2010) Mercedes C Becerra et al. LANCET
- The Population Dynamics and Control of Tuberculosis
- (2010) C. Dye et al. SCIENCE
- Mycobacterial outer membranes: in search of proteins
- (2010) Michael Niederweis et al. TRENDS IN MICROBIOLOGY
- A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
- (2010) Rustam I. Aminov Frontiers in Microbiology
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-ResistantMycobacterium tuberculosis
- (2009) Joel S. Freundlich et al. ChemMedChem
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
- (2009) Ali Akbar Velayati et al. CHEST
- Mycobacterium tuberculosis: drug resistance and future perspectives
- (2009) Giovanna Riccardi et al. Future Microbiology
- The introduction of ‘chemotherapy’ using arsphenamine – the first magic bullet
- (2009) KJ Williams JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
- (2009) Clifton E. Barry et al. NATURE REVIEWS MICROBIOLOGY
- Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption
- (2008) M. H. Scheetz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy
- (2008) Beata A. Wolucka FEBS Journal
- Lessons from Molecular Epidemiology and Comparative Genomics
- (2008) Barun Mathema et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now